Cargando…

Scoring of PD-L1 expression intensity on pulmonary adenocarcinomas and the correlations with clinicopathological factors

INTRODUCTION: The contribution of programmed cell death ligand-1 (PD-L1) immune checkpoint molecule toward progression of non-small cell lung cancer (NSCLC) has not yet been elucidated, in part, because of lack of a standardised method to evaluate PD-L1 expression. In this study, we developed a nove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Igarashi, Tomoyuki, Teramoto, Koji, Ishida, Mitsuaki, Hanaoka, Jun, Daigo, Yataro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070269/ https://www.ncbi.nlm.nih.gov/pubmed/27843633 http://dx.doi.org/10.1136/esmoopen-2016-000083

Ejemplares similares

Prognostic impact of soluble PD-L1 derived from tumor-associated macrophages in non-small-cell lung cancer
por: Teramoto, Koji, et al.
Publicado: (2023)

Oncogenic epidermal growth factor receptor signal-induced histone deacetylation suppresses chemokine gene expression in human lung adenocarcinoma
por: Sumimoto, Hidetoshi, et al.
Publicado: (2023)

RAS–Mitogen-Activated Protein Kinase Signal Is Required for Enhanced PD-L1 Expression in Human Lung Cancers
por: Sumimoto, Hidetoshi, et al.
Publicado: (2016)

Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine
por: Ohshio, Yasuhiko, et al.
Publicado: (2015)

Hypoxia-induced galectin-3 enhances RhoA function to activate the motility of tumor cells in non-small cell lung cancer
por: Kataoka, Yoko, et al.
Publicado: (2019)

Immunoexpression of PD-L1 and PD-1 and Its Clinicopathological Correlation in Urothelial Carcinomas
por: Kumar, Utpal, et al.
Publicado: (2021)

PD-L1 and PD-1 expression are correlated with distinctive clinicopathological features in papillary thyroid carcinoma
por: Bai, Yanhua, et al.
Publicado: (2017)

Prognostic significance of PD-L1-positive cancer-associated fibroblasts in patients with triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

Factors Associated with Cancer-Related Pain Requiring High-Dose Opioid Use in Palliative Cancer Patients
por: Sumimoto, Hidetoshi, et al.
Publicado: (2021)

Correlation between the Expression of PD-L1 and Clinicopathological Features in Patients with Thymic Epithelial Tumors
por: Chen, Yanmei, et al.
Publicado: (2018)

Solid histological component of adenocarcinoma might play an important role in PD‐L1 expression of lung adenocarcinoma
por: Miyazawa, Tomoyuki, et al.
Publicado: (2021)

Immunohistochemical comparison of three programmed death-ligand 1 (PD-L1) assays in triple-negative breast cancer
por: Yoshikawa, Katsuhiro, et al.
Publicado: (2021)

PD-L1 Expression in Non-Small-Cell Lung Cancer Including Various Adenocarcinoma Subtypes
por: Miyazawa, Tomoyuki, et al.
Publicado: (2018)

Diagnosis, clinicopathological characteristics and prognosis of pulmonary mucinous adenocarcinoma
por: Sun, Fei, et al.
Publicado: (2018)

PD-L1 Expression Correlated with Clinicopathological Factors and Akt/Stat3 Pathway in Oral SCC
por: Geum, Dong-Ho, et al.
Publicado: (2022)

Expression of PD-1/PD-L1 in primary breast tumours and metastatic axillary lymph nodes and its correlation with clinicopathological parameters
por: Yuan, Chenxi, et al.
Publicado: (2019)

Clinicopathological characteristics of pancreatic ductal adenocarcinoma with invasive micropapillary carcinoma component with emphasis on the usefulness of PKCζ immunostaining for detection of reverse polarity
por: Ryota, Hironori, et al.
Publicado: (2021)

Clinicopathological features and EGFR gene mutation status in elderly patients with resected non–small-cell lung cancer
por: Nishii, Teppei, et al.
Publicado: (2014)

Clinicopathological analysis of PD-L2 expression in colorectal cancer
por: Guo, Peng-Da, et al.
Publicado: (2018)

Correlation of pulmonary venous circulating tumor cells with clinicopathological parameters in patients with early-stage lung adenocarcinoma
por: Xu, Shi-Bin, et al.
Publicado: (2019)

Correlations Between the EGFR Mutation Status and Clinicopathological Features of Clinical Stage I Lung Adenocarcinoma
por: Isaka, Tetsuya, et al.
Publicado: (2015)

Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features
por: Watari, Jiro, et al.
Publicado: (2019)

Integrative assessment of clinicopathological parameters and the expression of PD-L1, PD-L2 and PD-1 in tumor cells of retroperitoneal sarcoma
por: Miyake, Makito, et al.
Publicado: (2020)

Correlation of PD-L1 Expression with Clinicopathological and Genomic Features in Chinese Non-Small-Cell Lung Cancer
por: Li, Yue, et al.
Publicado: (2022)

Evaluation of PD-L1 expression in a large set of gastroenteropancreatic neuroendocrine tumours and correlation with clinicopathological data
por: Rösner, Erik, et al.
Publicado: (2022)

Expression and function of Siglec-15 in RLPS and its correlation with PD-L1: Bioinformatics Analysis and Clinicopathological Evidence
por: Cui, Lixuan, et al.
Publicado: (2022)

PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules
por: Zhang, Yue, et al.
Publicado: (2022)

Clinicopathological assessment of PD-1/PD-L1 immune checkpoint expression in desmoid tumors
por: Hashimoto, Kazuhiko, et al.
Publicado: (2023)

The clinicopathologic of pulmonary adenocarcinoma transformation to small cell lung cancer
por: Yang, Haiyan, et al.
Publicado: (2019)

Association of histologic subtypes with genetic alteration and PD-L1 expression in pulmonary adenocarcinoma
por: Phruttinarakorn, Bantita, et al.
Publicado: (2020)

Evaluation of Glutaminase Expression in Prostate Adenocarcinoma and Correlation with Clinicopathologic Parameters
por: Myint, Zin W., et al.
Publicado: (2021)

Clinicopathological and Prognostic Significance of Immunoscore and PD-L1 in Intrahepatic Cholangiocarcinoma
por: Wu, Hong, et al.
Publicado: (2021)

PD-L1 expression and its clinicopathological correlation in advanced esophageal squamous cell carcinoma in a Chinese population
por: Rong, Lulu, et al.
Publicado: (2019)

PD-L1 Protein Expression and Gene Amplification Correlate with the Clinicopathological Characteristics and Prognosis of Lung Squamous Cell Carcinoma
por: Chen, Zhenwen, et al.
Publicado: (2021)

PD-L1 and EBV LMP1 expressions in classic Hodgkin lymphomas and its correlation with clinicopathological parameters and prognosis
por: ÖZDEMİR, Süleyman, et al.
Publicado: (2022)

Concordance, Correlation, and Clinical Impact of Standardized PD-L1 and TIL Scoring in SCCHN
por: De Keukeleire, Stijn Jeroen, et al.
Publicado: (2022)

Clinicopathological Features and Survival Outcomes of Primary Pulmonary Invasive Mucinous Adenocarcinoma
por: Gow, Chien-Hung, et al.
Publicado: (2021)

Immune profiles according to EGFR mutant subtypes and correlation with PD-1/PD-L1 inhibitor therapies in lung adenocarcinoma
por: Koh, Young Wha, et al.
Publicado: (2023)

A Comprehensive Peptidome Profiling Technology for the Identification of Early Detection Biomarkers for Lung Adenocarcinoma
por: Ueda, Koji, et al.
Publicado: (2011)

Tumor-infiltration of T-lymphocytes is inversely correlated with clinicopathologic factors in endometrial adenocarcinoma
por: Jung, In Kook, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k8bek3t4i29e5enkojqs66giev